Literature DB >> 24550525

Epigenetically modulated LRRC33 acts as a negative physiological regulator for multiple Toll-like receptors.

Xiaomin Su1, Shiyue Mei1, Xue Liang1, Shihua Wang2, Jingyi Liu1, Yuan Zhang1, Yue Bao1, Yanan Chen1, Yongzhe Che1, Robert Chunhua Zhao2, Zhujun Zhang3, Rongcun Yang4.   

Abstract

The members of a LRR family play crucial roles in the activation of innate and adaptive immune responses. We reported previously that LRRC33, a transmembrane protein of the LRR family, might potentially affect TLR-mediated activity. Here, we demonstrate that LRRC33 is a negative physiological regulator for multiple TLRs. Lrrc33(-/-) and Lrrc33(+/-) mice were more susceptible to TLR ligand challenges. The macrophages and DCs from Lrrc33(-/-) mice produced more proinflammatory cytokines than those of WT mice through increased activation of MAPK and NF-κB. Silencing LRRC33 also promoted multiple TLR-mediated activation in human moDCs. Notably, LRRC33 expression could be down-regulated by TLR ligands LPS, poly I:C, or PGN through H3K4me3 and H3K27me3 modification. In LPS-conditioned moDCs, reduced enrichment of H3K4me3 and increased H3K27me3 could be observed at the promoter region of LRRC33. Furthermore, silencing H3K4me3-associated factors MLL and RBBP5 not only decreased the enrichment of H3K4me3 but also down-regulated expression of LRRC33, whereas the expression of LRRC33 was up-regulated after silencing H3K27me3-associated factors EZH2 and EED. Thus, our results suggest that LRRC33 and TLRs may form a negative-feedback loop, which is important for the maintenance of immune homeostasis.
© 2014 Society for Leukocyte Biology.

Entities:  

Keywords:  H3K27me3; H3K4me3; dendritic cell; macrophage

Mesh:

Substances:

Year:  2014        PMID: 24550525     DOI: 10.1189/jlb.0813457

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  7 in total

1.  Editorial: dialing down inflammation: LRRC33 regulates Toll-like receptor signaling.

Authors:  Ann M Janowski; Fayyaz S Sutterwala
Journal:  J Leukoc Biol       Date:  2014-07       Impact factor: 4.962

2.  Loss of LRRC33-Dependent TGFβ1 Activation Enhances Antitumor Immunity and Checkpoint Blockade Therapy.

Authors:  Aiping Jiang; Yan Qin; Timothy A Springer
Journal:  Cancer Immunol Res       Date:  2022-04-01       Impact factor: 12.020

3.  A Milieu Molecule for TGF-β Required for Microglia Function in the Nervous System.

Authors:  Yan Qin; Brian S Garrison; Wenjiang Ma; Rui Wang; Aiping Jiang; Jing Li; Meeta Mistry; Roderick T Bronson; Daria Santoro; Charlotte Franco; Daisy A Robinton; Beth Stevens; Derrick J Rossi; Chafen Lu; Timothy A Springer
Journal:  Cell       Date:  2018-06-14       Impact factor: 41.582

4.  Enhancer of zeste homolog 2-catalysed H3K27 trimethylation plays a key role in acute-on-chronic liver failure via TNF-mediated pathway.

Authors:  Tianhui Zhou; Ye Sun; Ming Li; Yongsen Ding; Rongkun Yin; Ziqiang Li; Qing Xie; Shisan Bao; Wei Cai
Journal:  Cell Death Dis       Date:  2018-05-22       Impact factor: 8.469

5.  Biallelic mutations in NRROS cause an early onset lethal microgliopathy.

Authors:  Colin Smith; Barry W McColl; Anirudh Patir; Jack Barrington; Jeremy Armishaw; Antonia Clarke; Jenny Eaton; Vivienne Hobbs; Sahar Mansour; Melinda Nolan; Gillian I Rice; Mathieu P Rodero; Luis Seabra; Carolina Uggenti; John H Livingston; Leslie R Bridges; Iona J M Jeffrey; Yanick J Crow
Journal:  Acta Neuropathol       Date:  2020-02-25       Impact factor: 17.088

6.  Carvacrol, Thymol, and Garlic Essential Oil Promote Skin Innate Immunity in Gilthead Seabream (Sparus aurata) Through the Multifactorial Modulation of the Secretory Pathway and Enhancement of Mucus Protective Capacity.

Authors:  Joana P Firmino; Laura Fernández-Alacid; Eva Vallejos-Vidal; Ricardo Salomón; Ignasi Sanahuja; Lluis Tort; Antoni Ibarz; Felipe E Reyes-López; Enric Gisbert
Journal:  Front Immunol       Date:  2021-03-12       Impact factor: 7.561

7.  Toll-Like Receptor 4 Activation Contributes to Diabetic Bladder Dysfunction in a Murine Model of Type 1 Diabetes.

Authors:  Theodora Szasz; Camilla F Wenceslau; Beth Burgess; Kenia P Nunes; R Clinton Webb
Journal:  Diabetes       Date:  2016-09-20       Impact factor: 9.461

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.